TEL AVIV, Israel, Aug. 12, 2019 /PRNewswire/ -- ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals and specialty chemicals company, will participate at upcoming conferences:Mr. Charles Weidhas, ICL's COO, will participate at HSBC Global Emerging Markets Investor Forum in

PETAH TIKVA, Israel, Aug. 12, 2019 /PRNewswire/ -- PolyPid Ltd., a clinical-stage biopharmaceutical company focused on developing and commercializing novel, locally administered therapies, announced today that it has completed patient enrollment of 200 patients in its Phase 2 clinical trial evaluating D-PLEX100 for the preve

HANGZHOU and SHAOXING, China, Aug. 12, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today the opening of its Clinical Development Shanghai Center, signalling t

BOULDER, Colo., Aug. 12, 2019 /PRNewswire/ -- Encision Inc. (PK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced financial results for its fiscal 2020 first quarter that ended June 30, 2019.

WALNUT CREEK, Calif., Aug. 11, 2019 /PRNewswire/ -- Paradigm, the industry leader in solving catastrophic and complex health care challenges and improving lives, today announced its participation at the 74th Annual Workers' Compensation Education Conference and 30th Annual Safety & Health Conference, on August 10 - 13, 2019 in

SOUTH SAN FRANCISCO, Calif., Aug. 9, 2019 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) will announce its second quarter 2019 financial results after market close on Wednesday, August 14, 2019.  Following the release, Titan management will host a conference call at 4:30 p.m. EDT /

SUNRISE, Fla., Aug. 9, 2019 /PRNewswire/ -- U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced earnings for the second quarter that ended June 30, 2019. Correction: U.S. Stem Cell, Inc. posted seco

PHILADELPHIA, Aug. 9, 2019 /PRNewswire/ -- Six mission-driven, nonprofit academic health organizations across Greater Philadelphia and the Delaware Valley won a collective bid for the physician residency program at Hahnemann University Hospital. The move ensures access to patient care services—especially for the underserved&m

THOUSAND OAKS, Calif., Aug. 9, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. District Court for the District of New Jersey has ruled in Amgen's favor on validity of the two patents that describe and claim Enbrel® (etanercept) and methods for making it.Amgen affiliates Immunex Corporation and

LYNBROOK, N.Y., Aug. 9, 2019 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class collagenase-based product marketed as XIAFLEX® in the U.S. and Xiapex® in Europe, today announced its financial results for the secon